Pharmacological Treatment of H. Pylori Related Peptic Ulcer Disease

3 CE Credit Hours

Quick Overview

This course discusses the symptoms and etiology of peptic ulcer disease and the underlying pathophysiology of gastric and duodenal ulcers. We covered important points about the evaluation of patient with ulcers and important teaching points in patient education. Both pharmacologic and nonpharmacologic treatments are addressed. Discussed pharmacologic therapies, including antacids, H2 receptor antagonists, proton pump inhibitors, sucralfate, antiinfectives for H. pylori, and misoprostol.

$14.95

Email to a Friend

Description

Details

Completion Requirements

In order to receive full contact-hour credit for this CE activity, participants must:

Be registered for this activity,
Review the course material,
Complete the course post-test and obtain a grade of 70% or higher,
Complete and submit the course evaluation survey.
Other requirements for some of the courses may also include participation discussion boards, practice exercises, practice questions, etc.

Conflict of Interest (or lack thereof) for Planners, Authors and Presenters.

A conflict of interest exists if any individual/entity that is in a position to influence the content, design, or implementation of the CNE activity is ALSO in a position to benefit financially from the success of a CE activity.

The planners, authors and presenters of this CNE activity have disclosed no conflict of interest including no relevant financial relationships with any commercial companies pertaining to this CNE activity.

Commercial/Sponsor Support.

There is no commercial company or sponsor support for this CE activity.

Non-Endorsement of Products.

The CE provider approval status refers only to continuing nursing education activities and does not imply that there is a real or implied endorsement of any product, service, or company referred to in this activity nor of any company subsidizing costs related to the activity.

Off-Label Product Use.

This CE activity does not include any unannounced information about off-label use of a product for a purpose other than that for which it was approved by the Food and Drug Administration (FDA).

Course Aprrovals

Nursing Board Approvals National Healthcare Institute (NHI) is an approved provider of continuing nursing education by the California, Florida and District of Columbia Board of Nursing. All CE courses offer by National Healthcare Institute follow the standards recommended by the American Nurses Credentialing Center’s Commission on Accreditation for this type of educational activities.

California Board of Registered Nursing*

Registered Nurse

Florida Board of Nursing

Registered Nurse

Clinical Nurse Specialist

Advanced Registered Nurse Practitioner

District of Columbia Board of Nursing

Registered Nurse

Registered Nurse Anesthetist

Clinical Nurse Specialist

Clinical Nurse Midwife

Advanced Registered Nurse Practitioner

* Please note that the California Board of Registered Nursing (aka Registered Nursing Program) does not approve individual courses; however, as an approved CE provider (CA Provider 15701), National Healthcare Institute offers course content and utilize instructors who meet the requirements of Sections 1456 and 1457, Title 16, of the·California Code of Regulations in order to meet the CE requirements for nurses in the State of California.